Evid Invest
Who owns IBRXWhat IBRX owns — n/a

Who owns ImmunityBio, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of IBRX from SEC Form 13F filings across 405 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 405 institutions disclosed 207.1M shares of ImmunityBio, Inc. worth $1.95B — about 19.5% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.

405

13F holders

$1.95B

value, 2026 filers

19.5%

of shares outstanding (207.1M sh)

56

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of IBRX's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1BlackRock, Inc.36.1M$341.0M0.0%3.4%+6.0%
2STATE STREET CORP21.1M$199.1M0.0%2%-1.4%
3VANGUARD PORTFOLIO MANAGEMENT LLC19.4M$183.0M0.0%1.8%+8.5%
4VANGUARD CAPITAL MANAGEMENT LLC18.8M$177.5M0.0%1.8%+19.8%
5D. E. Shaw & Co., Inc.10.7M$101.1M0.0%1%-7.3%
6GEODE CAPITAL MANAGEMENT, LLC10.6M$100.1M0.0%1%+7.7%
7TWO SIGMA INVESTMENTS, LP5.8M$55.0M0.0%0.5%-47.5%
8CHARLES SCHWAB INVESTMENT MANAGEMENT INC4.9M$46.6M0.0%0.5%+70.8%
9GOLDMAN SACHS GROUP INC4.1M$39.0M0.0%0.4%+27.7%
10MILLENNIUM MANAGEMENT LLC3.8M$36.0M0.0%0.4%-31.6%
11UBS Group AG3.8M$35.6M0.0%0.4%+18.1%
12NORTHERN TRUST CORP3.7M$34.9M0.0%0.3%+3.6%
13VANGUARD FIDUCIARY TRUST CO2.8M$26.9M0.0%0.3%+18.1%
14SEB Asset Management AB2.4M$23.1M0.1%0.2%0.0%
15MORGAN STANLEY2.1M$20.1M0.0%0.2%-37.9%
16FEDERATED HERMES, INC.2.0M$18.5M0.0%0.2%+14.3%
17ROYAL BANK OF CANADA2.0M$18.4M0.0%0.2%+26.5%
18Woodline Partners LP1.9M$17.9M0.1%0.2%-24.1%
19PRINCIPAL FINANCIAL GROUP INC1.7M$16.4M0.0%0.2%+5779.0%
20BANK OF AMERICA CORP /DE/1.7M$16.3M0.0%0.2%-21.1%
21JPMORGAN CHASE & CO1.5M$13.1M0.0%0.1%+1.2%
22MARSHALL WACE, LLP1.5M$13.7M0.0%0.1%+274.1%
23Bank of New York Mellon Corp1.3M$12.4M0.0%0.1%+0.1%
24Trexquant Investment LP1.3M$12.4M0.1%0.1%+88.6%
25Cetera Investment Advisers1.2M$11.5M0.0%0.1%+7.1%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.